The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure
Abstract
AIMS: In addition to diabetes mellitus, less severe abnormalities of glucose and insulin metabolism may be related to functional status in patients with heart failure. We examined the relationship of hyperglycaemia (> or =6.1 mmol. l(-1)) and hyperinsulinaemia (> or =11.2 mU. l(-1)) to functional status and cardiac function in patients with heart failure. METHODS AND RESULTS: Fasting plasma glucose and insulin levels were obtained in 663 heart failure patients. The average left ventricular ejection fraction was 0.28+/-0.07, 63% were in New York Heart Association Functional Class (NYHA-FC) I/II and 37% were in NYHA-FC III/IV. Twenty seven percent had diabetes mellitus, but an additional 8% had undiagnosed diabetes mellitus (glucose > or =7 mmol. l(-1)) and 9% had glucose levels between 6.1 and 7 mmol. l(-1), so that a total of 43% (287) of patients had elevated glucose levels (> or =6.1 mmol. l(-1)). In general, more diabetic patients had NYHA-FC III/IV symptoms, shorter 6 min walk distances, but similar left ventricular ejection fractions compared to non-diabetic patients. The non-diabetic patients in NYHA-FC III/IV had higher glucose and insulin levels than patients in NYHA-FC I/II (6.3+/-0.2 vs 5.6+/-0.1 mmol. l(-1), P<0.001 and 19.6+/-2.3 vs 10. 2+/-0.6 mU. l(-1), P<0.001). Non-diabetic patients with elevated glucose levels had shorter 6 min walk distances compared to those with normal glucose levels (368.2+/-8 m vs 389.+/-4 m, P=0.02), however, left ventricular ejection fraction was similar. CONCLUSION: Glucose abnormalities are extremely common in heart failure patients (43% of patients). Diabetes mellitus and hyperglycaemia or hyperlinsulinaemia in non-diabetic patients were related to worse symptomatic status but not worsening left ventricular ejection fraction compared to patients with normal glucose and insulin levels.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Patients with T2DM and both HFrEF 1,34,69,70 and HFpEF 1 have worse NYHA functional class and more HF-related symptoms and signs than patients without T2DM, despite having similar ejection fraction.69,70”
From Type 2 diabetes mellitus and heart failure: A position statement from the Heart Failure Association of the European Society of Cardiology (2018) · cites this paper as [70]
Citations
Cites
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,325
The SOLVD Investigators* (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250501 · Cited by 8,029
(1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271003 · Cited by 3,725
Diabetes and Cardiovascular Disease: The Framingham Study
Kannel, W. B. (1979) · JAMA · doi:10.1001/jama.1979.03290450033020 · Cited by 2,936
Reaven, G. M., Lithell, H., & Landsberg, L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602083340607 · Cited by 1,435
Diabetes and cardiovascular disease
Howard, B. V., & Magee, M. F. (2000) · Current Atherosclerosis Reports · doi:10.1007/s11883-000-0046-8 · Cited by 1,386
Goldman, L., Hashimoto, B. E., Cook, E. F., & Loscalzo, A. (1981) · Circulation · doi:10.1161/01.cir.64.6.1227 · Cited by 974
Cowie, M., Struthers, A. D., Wood, D. A., Coats, A. J. S., Thompson, S. G., Poole-Wilson, P. A., & Sutton, G. C. (1997) · The Lancet · doi:10.1016/s0140-6736(97)06031-5 · Cited by 869
Effect of encouragement on walking test performance.
Guyatt, G. H., Pugsley, S. O., Sullivan, M. J., Thompson, P. J., Berman, L., Jones, N. L., Fallen, E. L., & Taylor, D. W. (1984) · Thorax · doi:10.1136/thx.39.11.818 · Cited by 816
Regulation of fatty acid oxidation in the mammalian heart in health and disease
Lopaschuk, G. D., Belke, D. D., Gamble, J., Toshiyuki, I., & Schönekess, B. O. (1994) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(94)00082-4 · Cited by 552
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–270 of 270
Cardiomyopathy of Insulin Resistance
Witteles, R. M., & Fowler, M. B. (2006) · Heart Failure Clinics · doi:10.1016/j.hfc.2005.11.007 · Cited by 4
Therapeutic patents for chronic heart failure: a review of patent applications from 1996 to 2002
Anker, S. D., Jankowska, E. A., & Okonko, D. O. (2004) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.14.5.639 · Cited by 4
Adipositas und kardiale Kachexie bei chronischer Herzinsuffizienz
Clauser, M., & Altenberger, J. (2013) · Herz · doi:10.1007/s00059-013-3885-0 · Cited by 5
Integrating preventive cardiology in primary care
Alaujan, B. S., Zamzami, B. A., Ababtain, H. A., Altalouhi, F. M., Alshammari, . H., Alenizi, E. S., Aldossary, G. F., Alshaibani, . S., Alowaidan, . R., Alharbi, A. F., et al. (2021) · International Journal of Health Sciences · doi:10.53730/ijhs.v5ns1.15060 · Cited by 3
Steinke, P., Schupp, T., Kuhn, L., Abumayyaleh, M., Ayoub, M., Mashayekhi, K., Bertsch, T., Ayasse, N., Jannesari, M., Siegel, F. P., et al. (2024) · Cardiovascular revascularization medicine · doi:10.1016/j.carrev.2024.12.001 · Cited by 3
Quality of Diabetes Care in the USA
Alencherry, B., & Bruemmer, D. (2021) · Current Cardiology Reports · doi:10.1007/s11886-021-01503-5 · Cited by 3
Romero, A., Saldarriaga, C., Ramos, C. E., Quesada, D., Chazzin, G., Fernández, F. N. G., Pow-Chon-Long, F., Alarco, W., Hurtado, P. E., Magaña, J. A., et al. (2023) · Archivos de cardiología de México · doi:10.24875/acm.23000059 · Cited by 3
ELEVATED TRIGLYCERIDE GLUCOSE INDEX IS RELATED TO THE PRESENCE OF HEART FAILURE
Şanlıalp, S. Ç., Nar, G., & Günver, M. G. (2021) · Journal of Istanbul Faculty of Medicine / İstanbul Tıp Fakültesi Dergisi · doi:10.26650/iuitfd.2021.898541 · Cited by 3
Variabilidade interensaios de dislipidemias em pacientes hipertensos
Rosini, N., Rosini, A. D., Rosini, G. D., Spada, C., Treitinger, A., & Mousse, D. M. (2009) · Jornal Brasileiro de Patologia e Medicina Laboratorial · doi:10.1590/s1676-24442009000400005 · Cited by 3
IMPAIRED GLUCOSE METABOLISM IN NONDIABETIC PATIENTS WITH ACUTE STROKE
Eslami, V., Sahraeian, Gheyni, M. R., Mahmoud, M., & Yazdani, T. (2008) · Cited by 3
Diabetes mellitus und Herzinsuffizienz: Epidemiologie und Therapie
Pfister, R., & Erdmann, E. (2008) · Herz · doi:10.1007/s00059-008-3113-5 · Cited by 3
Prevention of Congestive Heart Failure and Treatment of Asymptomatic Left Ventricular Dysfunction
McKelvie, R. S., Benedict, C., & Yusuf, S. (2002) · Wiley eBooks · doi:10.1002/9780470986882.ch45 · Cited by 3
Hormonal Therapy in the Treatment of Chronic Heart Failure
Napoli, R., Salzano, A., Bossone, E., & Cittadini, A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809657-4.64122-4 · Cited by 3
Metabolismo energético del corazón y sus proyecciones en el tratamiento de la insuficiencia cardíaca
Castro, P. F., Gabrielli, L., Verdejo, H., Greig, D., Mellado, R., Concepción, R., Sepúlveda, L., Vukasovic, J. L., García, L., Pizarro, M., et al. (2010) · Revista médica de Chile · doi:10.4067/s0034-98872010000800014 · Cited by 2
Insuficiencia cardíaca y diabetes. Una combinación de alto riesgo
Botta, C. E. (2009) · Redalyc (Universidad Autónoma del Estado de México) · Cited by 2
Ingelsson, E. (2008) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-008-0012-5 · Cited by 2
Cardiovascular Manifestations of Diabetes Mellitus: A Narrative Review of Literatures
Mostafavi-Pour-Manshadi, S. M. Y. (2016) · International Journal of Clinical and Experimental Medical Sciences · doi:10.11648/j.ijcems.20160205.11 · Cited by 1
Insuficiencia cardíaca y desarrollo de diabetes mellitus tipo 2
Roux, J. A. F., Benaiges, D., & Pedro‐Botet, J. (2011) · Medicina Clínica · doi:10.1016/j.medcli.2011.07.019 · Cited by 2
Xanthine Oxidase Inhibitors and Insulin Sensitizers
Doehner, W. (2005) · CRC Press eBooks · doi:10.1201/9780849333798.ch25 · Cited by 2
Rio‐Pertuz, G. D., Morataya, C., Parmar, K., Elharabi, Z., Davis, D. P., Abohelwa, M., Ochoa, O. J., Tran, A., NUGENT, K. M., Paniagua, D. E., et al. (2023) · Cardiovascular Endocrinology & Metabolism · doi:10.1097/xce.0000000000000285 · Cited by 1
New-Onset Diabetes in Heart Failure Patients: A Complex Relationship with Clinical Implications
Roux, J. A. F., Chillarón, J. J., Benaiges, D., & Pedro‐Botet, J. (2014) · Journal of Cardiology and Therapy · Cited by 1
Nichols, G. A., Koro, C. E., & Kolatkar, N. S. (2007) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2007.09.004 · Cited by 1
Metabolic Alterations in Diabetic Cardiomyopathy
Bordun, K.-A., Jassal, D. S., & Dhalla, N. S. (2013) · Springer eBooks · doi:10.1007/978-1-4614-9317-4_1 · Cited by 1
Fasting glycaemia is a predictor of outcome after acute myocardial infarction
Shofiullah, Patwary, M. I., Rahman, M., & Shahabuddin, S. (2016) · Bangabandhu Sheikh Mujib Medical University Journal · doi:10.3329/bsmmuj.v6i2.29129 · Cited by 1
OBSOLETE: Hormonal Therapy for Heart Failure
Cittadini, A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64122-3 · Cited by 1
Aldosterone and the mineralocorticoid receptor in insulin resistance and diabetes
Toloza, F. J. K., & Mendivil, C. O. (2017) · Alad · doi:10.24875/alad.m17000001
Tolkacheva, V. V., Diane, M. L., Khutsishvili, N. I., Montoya, F. E. C., Nazarov, I. S., Smirnov, I. P., Galochkin, S. A., & Kobalava, Z. D. (2024) · Bulletin of Siberian Medicine · doi:10.20538/1682-0363-2023-4-114-121 · Cited by 1
Cardiac Cachexia in Chronic Heart Failure: The Metabolic Facet of CHF
Doehner, W., & Anker, S. D. (2010) · Springer eBooks · doi:10.1007/978-1-84996-153-0_8 · Cited by 1
Anabolic Deficiencies in Heart Failure
Napoli, R., D’Assante, R., Miniero, M., Salzano, A., & Cittadini, A. (2022) · Cardiology Clinics · doi:10.1016/j.ccl.2021.12.003 · Cited by 1
Norhammar, A. (2003) · Figshare · Cited by 1
Dhand, S., Gozu, A., & Zolet, D. (2008) · Endocrine Practice · doi:10.4158/ep.14.6.691 · Cited by 1
Bacurau, A. V. N. (2013) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.39.2013.tde-07012014-083853 · Cited by 1
Rocchiccioli, P., & McMurray, J. J. V. (2009) · Wiley eBooks · doi:10.1002/9781444309768.ch46
The Endothelium, Cardiovascular Disease, and Therapy
Levine, T. B., & Levine, A. B. (2012) · Wiley eBooks · doi:10.1002/9781118480045.ch14
Straburzyńska‐Migaj, E., Szyszka, A., Ochotny, R., & Cieśliński, O. T. I. A. (2006) · Folia Cardiologica
Diabetes mellitus und Herzinsuffizienz
Pfister, R., & Schneider, C. A. (2011) · Der Diabetologe · doi:10.1007/s11428-011-0707-y
Hegab, Z. (2012) · Research Explorer (The University of Manchester)
Efectos pleiotrópicos de telmisartán en el paciente diabético
Tuñón, J., Ruiz‐Ortega, M., Martı́n-Ventura, J. L., Tarín, N., & Egido, J. (2007) · Revista Española de Cardiología Suplementos · doi:10.1016/s1131-3587(07)75232-9
Begum, N., Abdullah, A. S., Khan, M. A. H., Sultana, A. W., Osmany, D., & Mollah, F. H. (2014) · Chattagram Maa-O-Shishu Hospital Medical College Journal · doi:10.3329/cmoshmcj.v13i1.19409
Insulin Resistance and Progression of Heart Failure in the Older Adult
Sinha, S. S., & Shannon, R. P. (2011) · Aging Health · doi:10.2217/ahe.10.92
Glucose abnormalities and heart failure : Epidemiological and therapeutic aspects
Thrainsdottir, I. S. (2005) · Figshare
Straburzyńska‐Migaj, E., Szyszka, A., Ochotny, R., Trojnarska, O., & Cieśliński, A. (2006) · Via Medica Journals
Meyer, P., Hamel, A., de Denus, S., Racine, N., Ducharme, A., Nozza, A., Nigam, A., Juneau, M., Poirier, P., Gayda, M., et al. (2012) · Cardiovascular Endocrinology · doi:10.1097/xce.0b013e32835a2147
HEART FAILURE AND DIABETES MELLITUS: WHO SHOULD BE IN CHARGE ?
Dan, R., Petrescu, L., Timar, R. Z., & Dragulescu, S. I. (2009)
Klinik, A. D. M., & Kachexieforschung, A. A. (2015)
Archive of SID Impaired glucose metabolism in nondiabetic patients with acute stroke
Eslami, V., Sahraian, M. A., Gheini, M. R., & Motamedi, M. (2008)
Rudyk, I. S., Bolotskykh, G., & Udovychenko, M. (2015) · Biological Markers and Guided Therapy · doi:10.12988/bmgt.2015.5103
Review Article Cardiovascular Manifestations of Diabetes Mellitus: A Narrative Review of Literatures
Mohammad, S., Mostafavi-Pour-Manshadi, Y., Naderi, N., Dehghan, A., & Azizi, S. (2016)
de Melo, M. D. T. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2017.tde-15122017-121538
The role of the heart failure nurse and use of sodium glucose cotransporter-2 inhibitors
Melville, M. (2019) · British Journal of Cardiac Nursing · doi:10.12968/bjca.2019.0055
Mohan, M. (2019) · Discovery Research Portal (University of Dundee)
Methylglyoxal: a molecule in diabetic cardiovascular diseases
Nagarajan, D., & SUNNAGHATTA, N. S. (2021) · International Journal of Pharma and Bio Sciences · doi:10.22376/ijpbs.2017.8.1.b528-535
The role of thrombospondin-1-mediated TGF-b1 on collagen type III synthesis induced by high glucose
TangFenghua, M., & Zhang, Z. (2011)
Xanthine Oxidase Inhibitors and Insulin Sensitizers
Doehner, W. (2005) · CRC Press eBooks · doi:10.1201/9781420048957.ch25
The role of the heart failure nurse and use of sodium glucose cotransporter-2 inhibitors
Mellville, M. (2019) · Journal of Prescribing Practice · doi:10.12968/jprp.2019.1.12.602
- (2020) · Clinical endocrinology and endocrine surgery · doi:10.30978/cees-2020-3-97
Metformin Therapy in Heart Failure Patients with Pre-Diabetes and Diabetes
Hingorany, S. (2022) · Cardiology Research and Cardiovascular Medicine · doi:10.29011/2575-7083.100172
Zakaria, A. F., Hatta, S. F. W. M., Abidin, H. A. Z., Ismail, Z., & Ghani, R. A. (2022) · Research Square · doi:10.21203/rs.3.rs-2109398/v1
Pandey, A., Patel, K. V., & Verma, S. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch50
Cui, D.-Y., Zhang, C., Chen, Y., Qian, G.-Z., Zheng, W.-X., Zhang, Z.-H., Zhang, Y., & Zhu, P. (2024) · Figshare · doi:10.6084/m9.figshare.25708919
Zhou, Z., Liu, Q., Zheng, M., Zuo, Z., Zhang, G., Shi, R., & Wu, T. (2024) · Figshare · doi:10.6084/m9.figshare.26074138
The Role of the Heart in Cardiovascular-Kidney-Metabolic Syndrome
Stanciu, S., Pucerea, S., & Florescu, A.-G. (2025) · Springer eBooks · doi:10.1007/978-3-032-11445-7_13
Hyperpolarised 13C MRI in Cardiovascular Disease
Lau, C. W. Z., Boubertakh, R., Bryant, J., Toh, D., Le, T., Chin, C. W., & Hausenloy, D. J. (2026) · Journal of Asian Pacific Society of Cardiology · doi:10.15420/japsc.2025.23
Doehner, W., Friede, T., Edelmann, F., Landmesser, U., Winkler, S., Pieske, B. M., Knebel, F., Kelle, S., Tschöpe, D., Meyer, A., et al. (2025) · Global Cardiology · doi:10.4081/cardio.2025.89 · Cited by 1
Metabolic regulation and heart failure
Du, T., & Zhanpeng, H. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-34186-1.00022-0
Fontoura, D. (2010) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Torp-Pedersen, C., Metra, M., Charlesworth, A., Spark, P., Lukas, M. A., Poole-Wilson, P. A., Swedberg, K., Cleland, J. G. F., Di Lenarda, A., Remme, W. J., et al. (2007) · Heart · doi:10.1136/hrt.2006.092379 · Cited by 171
Sixt, S., Beer, S., Bluher, M., Korff, N., Peschel, T., Sonnabend, M., Teupser, D., Thiery, J., Adams, V., Schuler, G., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehp398 · Cited by 122
Metadata
- Authors
- Suskin, N.
- Affiliations
- London Health Sciences Centre (CA)
- Corresponding author
- Suskin, N
- ORCID
- Suskin, N
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2000-08-15
- Volume
- 21
- Issue
- 16
- Pages
- 1368-1375
- ISSN
- 0195-668X (ISSN-L)
- OpenAlex
- W2158721215
- Cited by
- 271
- References
- 28
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 10 · 2023: 6 · 2022: 8 · 2021: 12 · 2020: 6 · 2019: 18 · 2018: 7 · 2017: 7 · 2016: 11 · 2015: 9 · 2014: 11 · 2013: 11 · 2012: 18
- FWCI
- 3.46
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Heart Journal (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- congestive heart failure, hyperglycemia, hyperinsulinemia, glucose metabolism, insulin metabolism, functional capacity, NYHA functional class, 6-minute walk distance, left ventricular ejection fraction, diabetes mellitus, undiagnosed diabetes, cardiac function
- MeSH terms
- Blood Glucose, Diabetes Mellitus, Exercise Test, Female, Heart Failure, Humans, Hyperglycemia, Hyperinsulinism, Insulin, Insulin Resistance, Male, Middle Aged, Myocardial Contraction, Pilot Projects, Prognosis, Risk Factors, Stroke Volume, Cohort Studies, Biomarkers, Incidence, Ventricular Function, Left
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review